Precision medicine is ‘personalized, problematic, and promising’
The rapidly emerging field of precision medicine is a “disruptive innovation” that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week’s issue of the New England Journal of Medicine. Writing with oncologist Dan L. Longo, MD, a professor of Medicine at Harvard Medical School, in a “Sounding Board” piece, Jameson surveys the terrain of the new field.
The rapidly emerging field of precision medicine is a “disruptive innovation” that offers the possibility of remarkably fine-tuned remedies to improve patient health while minimizing the risk of harmful side effects, says J. Larry Jameson, MD, PhD, dean of the Perelman School of Medicine and executive vice president of the University of Pennsylvania for the Health System, in this week’s issue of the New England Journal of Medicine. Writing with oncologist Dan L. Longo, MD, a professor of Medicine at Harvard Medical School, in a “Sounding Board” piece, Jameson surveys the terrain of the new field.
SOURCE: Medical Xpress – Medical research News – Read entire story here.
